SAN DIEGO--The industrial genomics and bioinformatics company Sequenom announced last week that it had filed with the Securities and Exchange Commission for a public offering of common stock. The offering was led by Warburg Dillon Read, with assistance from Robertson Stephens and SG Cowen. The underwriters will be granted a 30-day over-allotment option to purchase additional shares of common stock from the company.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.